Commercial and HTA Policy in the UK
Instructor:
Leela Barham
Product ID: 705431
- Duration: 90 Min
Why Should You Attend:
The UK is a key market in Europe for launching new medicines with its tradition of free pricing and a world leading agencies for Health Technology Assessment (HTA) including the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC). Companies need to understand the two main options for the regulation of pharmaceutical prices in order to optimize the commercial opportunity for their products and portfolios whilst navigating the HTA landscape. Whilst HTA methods are key for individual products, shaping the policy environment for HTA affects portfolios and the industry as a whole. Upon completion of this webinar, attendees will understand:
- The history of the Pharmaceutical Price Regulation Scheme (PPRS) and how the 2014 PPRS has been shaped
- The advantages and disadvantages with of the UK’s unique approach to regulating prices; the voluntary PPRS
- The advantages and disadvantages with the UK’s Statutory Scheme for Branded Medicines
- Key issues shaping the future of policy on pricing in the UK
- How HTA fits into the PPRS and changes that cross the border between NICE and the commercial landscape in the NHS
Areas Covered in the Webinar:
- History of the PPRS
- History of the Statutory Scheme in the UK
- Key features of the PPRS
- Key features of the Statutory Scheme
- The link between the PPRS and HTA
Who Will Benefit:
- Government affairs and public policy professionals
- Strategic pricing personnel
- Market access professionals
- External affairs personnel
Leela Barham
Independent Health Economist, Leela Barham Economic Consulting Ltd
Leela Barham is an independent health economist and policy expert. She has worked on issues affecting the health care system and the pharmaceutical industry for over a decade.
Her work on the pharmaceutical industry has ranged from supporting a major research based pharmaceutical company on negotiations of the UK's Pharmaceutical Price Regulation Scheme (PPRS) to working with patient groups as they shape and influence policy that affects market access. She has worked beyond the UK too; working with others to benchmark countries Health Technology Assessment (HTA) systems as well as on issues affecting all markets including transparency.
She has a MSc in health economics from York University and a BSc in Economics from Nottingham University.
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
